XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.25.3

BASIS OF PRESENTATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Revision of Previously Issued Financial Statements | Accordingly, the Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the three months ended September 30, 2024:
(In thousands, except per share data) | As previously reported |  | Impact of revision |  | As adjusted
Condensed Consolidated Statement of Operations |  |  |  |  |
Revenue: |  |  |  |  |
Financial Health | $ | 54,271 |  |  | $ | 401 |  |  | $ | 54,672 |
Patient Care | 29,559 |  |  | 469 |  |  | 30,028 |
Total revenue | $ | 83,830 |  |  | $ | 870 |  |  | $ | 84,700 |
Operating income | 1,944 |  |  | 870 |  |  | 2,814 |
Income (loss) before taxes | (2,465) |  |  | 870 |  |  | (1,595) |
Provision for income taxes | 7,344 |  |  | 209 |  |  | 7,553 |
Net income (loss) | (9,809) |  |  | 661 |  |  | (9,148) |
Net income (loss) per share - basic | $ | (0.66) |  |  | $ | 0.05 |  |  | (0.61) |
Net income (loss) per share - diluted | $ | (0.66) |  |  | $ | 0.05 |  |  | (0.61) |
Condensed Consolidated Statement of Comprehensive Income (Loss) |  |  |  |  |
Net income (loss) | $ | (9,809) |  |  | $ | 661 |  |  | $ | (9,148) |
Comprehensive income (loss) | (9,810) |  |  | 661 |  |  | (9,149) |
Condensed Consolidated Statement of Equity |  |  |  |  |
Accumulated earnings (deficit) at June 30, 2024 | $ | 567 |  |  | $ | (1,322) |  |  | $ | (755) |
Total stockholders’ equity at June 30, 2024 | 181,102 |  |  | (1,322) |  |  | 179,780 |
Net income (loss) | (9,809) |  |  | 661 |  |  | (9,148) |
Accumulated earnings (deficit) at September 30, 2024 | (9,242) |  |  | (661) |  |  | (9,903) |
Total stockholders’ equity at September 30, 2024 | 172,647 |  |  | (661) |  |  | 171,986 |
The Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the nine months ended September 30, 2024:
(In thousands, except per share data) | As previously reported |  | Impact of revision |  | As adjusted
Condensed Consolidated Statement of Operations |  |  |  |  |
Revenue: |  |  |  |  |
Financial Health | $ | 161,417 |  |  | $ | 1,203 |  |  | $ | 162,620 |
Patient Care | 90,389 |  |  | 1,407 |  |  | 91,796 |
Total revenue | $ | 251,806 |  |  | $ | 2,610 |  |  | $ | 254,416 |
Operating income (loss) | (2,534) |  |  | 2,610 |  |  | 76 |
Income (loss) before taxes | (13,743) |  |  | 2,610 |  |  | (11,133) |
Provision for (benefit from) income taxes | 3,631 |  |  | 626 |  |  | 4,257 |
Net income (loss) | (17,374) |  |  | 1,984 |  |  | (15,390) |
Net income (loss) per share - basic | $ | (1.17) |  |  | $ | 0.13 |  |  | (1.04) |
Net income (loss) per share - diluted | $ | (1.17) |  |  | $ | 0.13 |  |  | (1.04) |
Condensed Consolidated Statement of Comprehensive Income (Loss) |  |  |  |  |
Net income (loss) | $ | (17,374) |  |  | $ | 1,984 |  |  | $ | (15,390) |
Comprehensive income (loss) | (17,267) |  |  | 1,984 |  |  | (15,283) |
Condensed Consolidated Statement of Equity |  |  |  |  |
Accumulated earnings (deficit) at December 31, 2023 | $ | 8,132 |  |  | $ | (2,645) |  |  | $ | 5,487 |
Total stockholders’ equity at December 31, 2023 | 186,618 |  |  | (2,645) |  |  | 183,973 |
Net income (loss) | (17,374) |  |  | 1,984 |  |  | (15,390) |
Accumulated earnings (deficit) at September 30, 2024 | (9,242) |  |  | (661) |  |  | (9,903) |
Total stockholders’ equity at September 30, 2024 | 172,647 |  |  | (661) |  |  | 171,986 |
Condensed Consolidated Statement of Cash Flows |  |  |  |  |
Net income (loss) | $ | (17,374) |  |  | $ | 1,984 |  |  | $ | (15,390) |
Accounts receivable | 2,946 |  |  | (2,610) |  |  | 336 |
Income taxes, net | (344) |  |  | 626 |  |  | 282 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration